*****COURSES ARE SUBJECT TO CHANGE*****
Recommended for students interested in careers in the biopharmaceutical industry. Focuses on recombinant DNA technology and the drug-development process, including discovery research; preclinical testing; clinical trials; and regulatory review, as well as manufacturing and production considerations. Students may not receive credit for this course and course 255. Prerequisite(s): Biology 20A and either Chemistry 103 or Biology 100 or Biochemistry and Molecular Biology 100A. Enrollment limited to 15. P. Berman
While the information on this web site is usually the most up to date, in the event of a discrepancy please contact your adviser to confirm which information is correct.